drugset / Trial / NCT03381209

The Effect of Sugammadex Given Based on Ideal, Actual or Adjusted Body Weight on Reversal of Rocuronium.

NCT03381209

Completed 60 enrolled Ain Shams University
RandomizedParallel-groupDouble-blindHealth-services research

Summary

The aim of this study is compare the reversal of rocuronium induced neuromuscular blockade in morbidly obese patients using three doses of sugammadex; based on ideal body weight, adjusted body weight, and actual body weight.

Timeline

Start
2017-06-10
Primary completion
2017-11-10
Completion
2017-11-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Sugammadex Other / unclassified 2 mg/kg

Indications

No indication recorded.